2M6

MEDTRONIC PLC DL,0001

Stock XETRA – Stock Market Prices, News & Analysis

Medtronic est un leader mondial dans la conception, la fabrication et la commercialisation de médicales innovantes pour le traitement de diverses pathologies.

€ 74.85
0.55 %

MEDTRONIC PLC DL,0001

74.85
0.55 %
2M6

Medtronic est un leader mondial dans la conception, la fabrication et la commercialisation de médicales innovantes pour le traitement de diverses pathologies.

Price history of MEDTRONIC PLC DL,0001
Price history of MEDTRONIC PLC DL,0001

Performance & Momentum

6 Months 6.26 %
1 Year 4.52 %
3 Years 13.91 %
5 Years 11.46 %

Strategic Analysis

MEDTRONIC PLC DL,0001 • 2026

Medtronic positions itself as a global leader in medical , combining innovation and expertise to develop advanced medical devices addressing a broad range of conditions. Its model is built on the diversification of its healthcare solutions and its ability to innovate in order to maintain a competitive edge in a demanding sector.

Strengths
  • Recognized global leadership in the medical devices sector
  • Diversified portfolio of technological innovations dedicated to medical treatments
  • Strong positioning in markets with high medical needs and sustainable growth
Weaknesses
  • Moderate stock performance over the medium term
  • Sensitivity to regulatory changes and healthcare investment cycles
Momentum

The moderate momentum reflects relative stability despite pressure on annual performance. The lack of recent news reinforces the view of a wait-and-see phase, where investors may be awaiting catalysts such as new product launches or clinical results before considering an upward trend.

Analysis performed 1 week ago

Similar stocks to MEDTRONIC PLC DL,0001

Was this page helpful?

Your feedback helps us improve our research.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases
Anantys Invest on iPhone